No valuation for Coherent Biopharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($130.0M) and the funding record below are the closest available signals.
- ·100 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Coherent Biopharma funding history
No funding rounds for Coherent Biopharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Recent activity
In the last 90 days, Coherent Biopharma's record added 9 institutional fund marks (latest period Jul 2026).
Institutional holders and vehicles
11 SEC-registered funds reported 100 fair-value marks on Coherent Biopharma between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Coherent Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Coherent Biopharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Coherent Biopharma
- How much has Coherent Biopharma raised?
- Coherent Biopharma has raised $130.0M in total funding across its recorded rounds.